Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2032-07-15
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies the effects of stereotactic body radiation therapy followed
by surgery in treating patients with stage I-IIIA non-small cell lung cancer. Stereotactic
body radiation therapy is a method of radiation that uses imaging to precisely locate a tumor
and then deliver very high radiation doses to the tumor site in order to limit normal tissue
toxicity or damage.